Wall Street Zen Downgrades Celsius (NASDAQ:CELH) to Hold

Celsius (NASDAQ:CELH) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Sunday.

CELH has been the topic of a number of other research reports. Needham & Company LLC reiterated a “buy” rating and issued a $60.00 price objective (up previously from $55.00) on shares of Celsius in a research report on Thursday, August 7th. JPMorgan Chase & Co. increased their price objective on Celsius from $44.00 to $54.00 and gave the stock an “overweight” rating in a research report on Thursday, July 31st. Wells Fargo & Company increased their price objective on Celsius from $44.00 to $45.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 4th. TD Cowen raised Celsius from a “hold” rating to a “buy” rating and increased their target price for the company from $37.00 to $55.00 in a research note on Monday, June 16th. Finally, Stifel Nicolaus raised their price target on Celsius from $50.00 to $56.00 and gave the company a “buy” rating in a research report on Friday, August 8th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, Celsius presently has an average rating of “Moderate Buy” and a consensus price target of $52.28.

Celsius Trading Up 1.1%

Shares of CELH stock opened at $57.30 on Friday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 2.11. Celsius has a 52-week low of $21.10 and a 52-week high of $57.79. The company has a market capitalization of $14.78 billion, a PE ratio of 154.86, a price-to-earnings-growth ratio of 1.31 and a beta of 1.40. The business’s fifty day moving average is $46.13 and its 200 day moving average is $37.19.

Celsius (NASDAQ:CELH) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.23 by $0.24. Celsius had a return on equity of 36.88% and a net margin of 7.91%. The company had revenue of $739.30 million for the quarter, compared to the consensus estimate of $632.13 million. During the same quarter last year, the business posted $0.28 earnings per share. The firm’s revenue was up 83.9% compared to the same quarter last year. On average, equities research analysts anticipate that Celsius will post 0.89 EPS for the current fiscal year.

Insider Buying and Selling

In other news, CFO Jarrod Langhans sold 5,000 shares of the firm’s stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $51.18, for a total transaction of $255,900.00. Following the transaction, the chief financial officer directly owned 109,227 shares of the company’s stock, valued at approximately $5,590,237.86. This trade represents a 4.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Deborah Desantis sold 100,000 shares of the firm’s stock in a transaction dated Thursday, July 31st. The shares were sold at an average price of $47.50, for a total value of $4,750,000.00. Following the transaction, the insider directly owned 17,717,770 shares in the company, valued at $841,594,075. This trade represents a 0.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,111,141 shares of company stock valued at $52,241,605 over the last three months. 2.55% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Evergreen Capital Management LLC grew its stake in shares of Celsius by 9.2% during the second quarter. Evergreen Capital Management LLC now owns 6,530 shares of the company’s stock valued at $303,000 after buying an additional 551 shares during the last quarter. Corient Private Wealth LLC grew its stake in shares of Celsius by 67.7% during the second quarter. Corient Private Wealth LLC now owns 13,356 shares of the company’s stock valued at $620,000 after buying an additional 5,393 shares during the last quarter. E Fund Management Co. Ltd. bought a new position in shares of Celsius during the second quarter valued at about $1,035,000. Captrust Financial Advisors grew its stake in shares of Celsius by 90.9% during the second quarter. Captrust Financial Advisors now owns 12,713 shares of the company’s stock valued at $590,000 after buying an additional 6,052 shares during the last quarter. Finally, Blue Chip Partners LLC grew its stake in shares of Celsius by 2.4% in the second quarter. Blue Chip Partners LLC now owns 11,701 shares of the company’s stock worth $543,000 after purchasing an additional 271 shares during the last quarter. 60.95% of the stock is owned by institutional investors.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.